首页 | 本学科首页   官方微博 | 高级检索  
检索        

4-羟基-2-(1H-吡唑-1-基)嘧啶-5-甲酸的合成工艺改进研究
引用本文:郭慧敏,高骏,段玉清,毕常芬,王绍杰,李祎亮.4-羟基-2-(1H-吡唑-1-基)嘧啶-5-甲酸的合成工艺改进研究[J].现代药物与临床,2018,33(12):3092-3095.
作者姓名:郭慧敏  高骏  段玉清  毕常芬  王绍杰  李祎亮
作者单位:天津技术产权交易有限公司, 天津 300203,沈阳药科大学, 辽宁 本溪 117004;中国医学科学院 北京协和医学院 放射医学研究所, 天津 300192,中国医学科学院 北京协和医学院 放射医学研究所, 天津 300192,中国医学科学院 北京协和医学院 放射医学研究所, 天津 300192,沈阳药科大学, 辽宁 本溪 117004,中国医学科学院 北京协和医学院 放射医学研究所, 天津 300192
基金项目:天津市自然科学基金青年项目(18JCQNJC09500);中国医学科学院医学与健康科技创新工程项目(2016-I2M-3-022);中央高校基本业务费项(3332018117)
摘    要:目的对4-羟基-2-(1H-吡唑-1-基)嘧啶-5-甲酸的合成工艺条件进行优化。方法以1-脒基吡唑盐酸盐和乙氧基甲叉基丙二酸二乙酯为起始原料,在三乙胺催化下环合得到中间体4-羟基-2-(1H-吡唑-1-基)嘧啶-5-甲酸乙酯,再经过氢氧化锂在四氢呋喃–水混合溶剂中水解得到目标化合物。结果合成了目标化合物,经MS、1H-NMR确证了结构,质量分数为99.5%,本合成工艺的总收率为87%。结论该合成工艺具有操作简单、反应条件温和、成本低、产率和纯度较高等优点,适合工业化生产。

关 键 词:脯氨酰羟化酶抑制剂  4-羟基-2-(1H-吡唑-1-基)嘧啶-5-甲酸  合成工艺
收稿时间:2018/11/2 0:00:00

Improvement of synthetic process of 4-hydroxy-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxylic acid
GUO Hui-min,GAO Jun,DUAN Yu-qing,BI Chang-fen,WANG Shao-jie and LI Yi-liang.Improvement of synthetic process of 4-hydroxy-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxylic acid[J].Drugs & Clinic,2018,33(12):3092-3095.
Authors:GUO Hui-min  GAO Jun  DUAN Yu-qing  BI Chang-fen  WANG Shao-jie and LI Yi-liang
Institution:Tianjin Technology Property Rights Exchange Co., Ltd, Tianjin 300203, China,Shenyang Pharmaceutical University, Benxi 117004, China;Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192, China,Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192, China,Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192, China,Shenyang Pharmaceutical University, Benxi 117004, China and Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192, China
Abstract:Objective To optimize the synthetic process of 4-hydroxy-2-(1H-pyrazol-1-yl)-pyrimidine-5-carboxylic acid. Methods 1-Amidinopyrazole hydrochloride and diethylethoxymethylenemalonate were used as starting materials to obtain the intermediate ethyl 4-hydroxy-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxylate through cyclization catalyzed by triethylamine. The title compound was obtained via hydrolysis by lithium hydroxide in mixed solvent of water and tetrahydrofuran. Results The target compound was synthesized and characterized by MS and 1H-NMR. And the purity was 99.5%, and the total yield of this route was 87%. Conclusion The synthetic process has the advantages of simple operations, mild reaction conditions, low cost, high yield and purity, and is more suitable for industrial production.
Keywords:prolyl hydroxylase inhibitor  4-hydroxy-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxylic acid  synthetic process
本文献已被 CNKI 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号